NSG 6001 Week 3 Midterm 2026/2027 | 80+ Questions & Correct Answers | GI, GERD, Liver, UTI, BPH, Prostate Disorders, STIs & Reproductive Health

This NSG 6001 Week 3 Midterm 2026/2027 is an 18-page updated exam-preparation resource containing 80+ questions and correct answers focused on gastrointestinal, hepatobiliary, genitourinary, male and female reproductive, and sexually transmitted infection topics. The questions emphasize history taking, physical assessment, differential diagnosis, diagnostic testing, pharmacological treatment, patient education, prevention, and clinical decision-making. Major topics include abdominal pain, constipation, diarrhea, appendicitis, irritable bowel syndrome, GERD, peptic ulcer disease, cholelithiasis, hepatitis, liver disorders, urinary tract infections, BPH, prostatitis, prostate and testicular cancer, epididymitis, testicular torsion, gonorrhea, chlamydia, syphilis, trichomoniasis, HPV, genital herpes, bacterial vaginosis, and pelvic inflammatory disease. The gastrointestinal assessment and diagnosis section begins with common primary-care presentations such as abdominal pain, constipation, diarrhea, and meal-related gastrointestinal symptoms. Students review important components of an abdominal-pain history, including the nature and timing of pain, provoking and relieving factors, and associated nausea or vomiting. Diarrhea assessment includes frequency, amount, consistency, color, diet, travel, medication use, and drinking-water source. The questions also address appendicitis, emphasizing history and physical examination and identifying vague abdominal discomfort as an early manifestation. Irritable bowel syndrome material includes constipation alternating with diarrhea, abdominal distention, flatulence, improvement after bowel movements, and dietary management with increased fiber as presented in the document. A substantial portion covers GERD, hiatal hernia, peptic ulcer disease, and hepatobiliary disorders. GERD questions review pyrosis, dietary modification, elimination of coffee, and activity considerations, while hiatal-hernia management emphasizes avoiding lying down after meals. The document discusses water brash, Barrett’s esophagus, histamine H2-receptor antagonists, NSAID-associated peptic ulcer disease, and right-upper-quadrant pain associated with suspected cholelithiasis. Elevated alkaline phosphatase is given as an expected laboratory finding in the cholelithiasis scenario. The liver and hepatitis material covers hepatitis A and B risk, vaccination of healthcare workers, liver biopsy, hyperammonemia, lactulose therapy, hemochromatosis, portal hypertension, fatty liver, and the liver as an important site of metastatic disease. The questions identify bleeding as a critical complication to assess following liver biopsy and discuss lactulose in relation to elevated ammonia. Macrovesicular fatty liver content emphasizes alcohol avoidance, while a hemochromatosis question addresses why women may experience manifestations later, particularly after menopause. The urinary and genitourinary section reviews lower urinary tract infection manifestations and special considerations in older adults. Cloudy urine is presented as an expected UTI finding, while altered mental status is emphasized in an elderly patient. Pharmacology questions include trimethoprim-sulfamethoxazole and ciprofloxacin, including interactions with antacids. The material then transitions into male reproductive anatomy, PSA assessment, corpus spongiosum anatomy, testicular self-examination, nocturia, urinary incontinence, and benign prostatic hypertrophy. Male reproductive disorders receive detailed coverage through BPH, prostatitis, prostatodynia, epididymitis, testicular torsion, hydrocele, Peyronie’s disease, erectile dysfunction, prostate cancer, and testicular cancer. Questions address finasteride-associated erectile dysfunction, gram-negative organisms in acute prostatitis, prolonged TMP-SMX treatment as presented for chronic prostatitis, terazosin for prostatodynia, and Chlamydia trachomatis in epididymitis. Scrotal ultrasound is identified for confirming epididymitis, while scrotal elevation is included in treatment. The exam emphasizes an absent cremasteric reflex in testicular torsion and immediate urological referral for a 14-year-old presenting with severe testicular pain. The prostate and testicular cancer questions extend into PSA interpretation, DRE findings, the Jewett staging system, leuprolide adverse effects, radical orchidectomy, and post-treatment surveillance. The document associates C2 prostate cancer with seminal-vesicle involvement and reviews leuprolide-related effects such as hot flashes, gynecomastia, erectile dysfunction, osteoporosis, reduced muscle mass, and testicular changes. Radical orchidectomy is identified as the treatment choice in the testicular-cancer question. A major final section concentrates on sexually transmitted infections and reproductive health. The exam covers gonorrhea, chlamydia, bacterial vaginosis, trichomoniasis, syphilis, genital herpes, HPV/genital warts, Phthirus pubis, hepatitis B, and pelvic inflammatory disease. Clinical clues include clue cells with bacterial vaginosis, chancre and gummas with syphilis, vesicular lesions with genital herpes, verrucous growths with HPV, and a strawberry cervix with trichomoniasis. The document gives ceftriaxone as its treatment answer for gonorrhea and metronidazole for trichomoniasis. It also identifies chlamydia as the most commonly diagnosed STI in the United States within the study material. Prevention and patient education are integrated throughout the STI questions. The resource explains that condoms reduce but do not eliminate STI risk, alcohol may increase risk by reducing inhibitions, sharing intravenous drug equipment can transmit infection, and abstinence is presented as the best prevention strategy. It also addresses standard precautions, partner notification, ophthalmia neonatorum, neonatal management following maternal hepatitis B, Pap testing, colposcopy, and severe pain during bimanual pelvic examination as a finding associated with pelvic inflammatory disease. Relevant students: NSG 6001 students, advanced nursing students, Family Nurse Practitioner students, FNP students, Adult-Gerontology Nurse Practitioner students, AGNP students, MSN students, DNP students, APRN students, graduate nursing students, primary care nurse practitioner students, advanced health assessment students, clinical diagnosis students, reproductive health students, women’s health nursing students, adult primary care students, nurse practitioner midterm candidates Source accuracy note: The uploaded document explicitly identifies the assessment as NSG 6001 Week 3 Midterm and the academic period as 2026/2027, describing the material as updated exam questions and correct answers. It does not identify a university, referenced textbook, peer-reviewed journal, DOI, or formal APA bibliography. No unsupported institution or academic citation has therefore been added. Keywords: NSG 6001 Week 3 Midterm, NSG 6001 Midterm 2026, NSG 6001 Midterm 2026/2027, NSG 6001 questions and answers, NSG 6001 study guide, NSG 6001 exam questions, advanced nursing midterm, FNP midterm exam, abdominal pain assessment, appendicitis, irritable bowel syndrome, IBS, GERD, hiatal hernia, peptic ulcer disease, cholelithiasis, hepatitis A, hepatitis B, liver disorders, lactulose, urinary tract infection, UTI, ciprofloxacin, BPH, benign prostatic hypertrophy, prostatitis, epididymitis, testicular torsion, Peyronie disease, prostate cancer, testicular cancer, gonorrhea, chlamydia, syphilis, trichomoniasis, genital herpes, HPV, genital warts, bacterial vaginosis, pelvic inflammatory disease, STI prevention, reproductive health, genitourinary disorders, primary care nursing